1	Pfizers	pfizers	NNS	p2=NNPS	2	nn	_
2	pursuit	pursuit	NN	p2=VBP	7	nsubj	7:A0=PAG
3	of	of	IN	_	2	prep	_
4	AstraZeneca	astrazeneca	NNP	_	3	pobj	_
5	may	may	MD	_	7	aux	7:AM-MOD
6	be	be	VB	_	7	aux	_
7	drawing	draw	VBG	pb=draw.02	0	root	_
8	to	to	IN	_	7	prep	7:A2=DIR
9	a	a	DT	_	10	det	_
10	close	close	NN	_	8	pobj	_
11	.	.	.	_	7	punct	_

1	On	on	IN	_	5	prep	5:AM-TMP
2	Monday	monday	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0=PAG
5	rejected	reject	VBD	pb=reject.01	0	root	_
6	Pfizers	pfizers	NNP	p2=NNS	5	dobj	5:A1=PPT
7	latest	late	JJS	_	5	npadvmod	5:AM-TMP
8	and	and	CC	_	7	cc	_
9	what	what	WP	_	11	dobj	11:R-A1
10	it	it	PRP	_	11	nsubj	11:A0=PAG
11	described	describe	VBD	pb=describe.01	7	conj	_
12	as	as	IN	_	11	prep	11:A2=PRD
13	its	its	PRP$	_	16	poss	_
14	final	final	JJ	_	16	amod	_
15	takeover	takeover	NN	_	16	nn	_
16	bid	bid	NN	_	12	pobj	_
17	.	.	.	_	5	punct	_

1	In	in	IN	_	6	prep	6:AM-TMP
2	recent	recent	JJ	_	3	amod	_
3	weeks	week	NNS	_	1	pobj	_
4	Pfizer	pfizer	NNP	_	6	nsubj	6:A0
5	has	have	VBZ	_	6	aux	_
6	made	make	VBN	pb=make.LV	0	root	_
7	repeated	repeat	VBN	p2=JJ|pb=repeat.01	8	amod	_
8	approaches	approach	NNS	_	6	dobj	7:A1=PPT;6:AM-PRR
9	to	to	IN	p2=TO	6	prep	6:A2
10	AstraZeneca	astrazeneca	NNP	_	9	pobj	_
11	,	,	,	_	10	punct	_
12	both	both	CC	p2=DT	13	preconj	_
13	privately	privately	RB	_	24	advmod	24:AM-MNR
14	and	and	CC	_	13	cc	_
15	publicly	publicly	RB	_	13	conj	_
16	,	,	,	_	6	punct	_
17	and	and	CC	_	6	cc	_
18	the	the	DT	_	22	det	_
19	Anglo	anglo	JJ	p2=NNP	21	hmod	_
20	-	-	HYPH	_	21	hyph	_
21	Swedish	swedish	JJ	p2=NNP	22	amod	_
22	drugmaker	drugmaker	NN	_	24	nsubj	24:A0=PAG
23	has	have	VBZ	_	24	aux	_
24	rebuffed	rebuff	VBN	pb=rebuff.01	6	conj	_
25	them	them	PRP	_	24	dobj	24:A1=PPT
26	all	all	DT	p2=RB	25	appos	_
27	as	as	IN	p2=RB	24	prep	24:AM-PRD
28	too	too	RB	_	29	advmod	_
29	low	low	JJ	_	27	amod	_
30	.	.	.	_	24	punct	_

1	The	the	DT	_	3	det	_
2	latest	late	JJS	_	3	amod	_
3	offer	offer	NN	p2=VBP	9	nsubj	9:A1=PPT
4	,	,	,	_	3	punct	_
5	made	make	VBN	p2=VBD|pb=make.02	3	partmod	_
6	Sunday	sunday	NNP	_	7	nn	_
7	evening	evening	NN	_	5	oprd	5:A1=PRD
8	,	,	,	_	9	punct	_
9	was	be	VBD	pb=be.01	0	root	_
10	worth	worth	JJ	_	9	acomp	9:A2=PRD
11	about	about	IN	_	14	quantmod	_
12	$	$	$	_	14	quantmod	_
13	119	0	CD	_	14	number	_
14	billion	#crd#	CD	_	10	npadvmod	_
15	.	.	.	_	9	punct	_

1	On	on	IN	_	5	prep	5:AM-TMP
2	Monday	monday	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0
5	said	say	VBD	pb=say.01	0	root	_
6	the	the	DT	_	8	det	_
7	increased	increase	VBN	p2=VBD|pb=increase.01	8	amod	_
8	bid	bid	NN	_	9	nsubj	9:A0=PAG;7:A1=PPT
9	undervalues	undervalue	VBZ	p2=IN|pb=undervalue.01	5	ccomp	5:A1=PPT
10	the	the	DT	_	11	det	_
11	company	company	NN	_	9	dobj	9:A1=PPT
12	and	and	CC	_	11	cc	_
13	its	its	PRP$	_	15	poss	_
14	attractive	attractive	JJ	_	15	amod	_
15	prospects	prospect	NNS	_	11	conj	_
16	.	.	.	_	5	punct	_

1	Pfizer	pfizer	NNP	p2=NN	14	nsubj	4:A0=PAG;14:A0
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	4	nsubj	4:R-A0
4	began	begin	VBD	pb=begin.01	1	rcmod	_
5	its	its	PRP$	_	6	poss	_
6	pursuit	pursuit	NN	_	4	dobj	4:A1=PPT
7	of	of	IN	_	6	prep	_
8	a	a	DT	_	9	det	_
9	merger	merger	NN	_	7	pobj	_
10	last	last	JJ	_	11	amod	_
11	year	year	NN	_	9	npadvmod	_
12	,	,	,	_	14	punct	_
13	has	have	VBZ	_	14	aux	_
14	said	say	VBD	p2=VBN|pb=say.01	0	root	_
15	it	it	PRP	_	18	nsubj	18:A0=PAG
16	will	will	MD	_	18	aux	18:AM-MOD
17	not	not	RB	_	18	neg	18:AM-NEG
18	make	make	VB	pb=make.02	14	ccomp	14:A1=PPT
19	a	a	DT	_	21	det	_
20	hostile	hostile	JJ	_	21	amod	_
21	bid	bid	NN	_	18	dobj	18:AM-PRR
22	for	for	IN	_	21	prep	_
23	AstraZeneca	astrazeneca	NNP	_	22	pobj	_
24	.	.	.	_	14	punct	_

1	Under	under	IN	_	8	prep	8:AM-LOC
2	British	british	JJ	_	4	amod	_
3	takeover	takeover	NN	_	4	nn	_
4	rules	rule	NNS	_	1	pobj	_
5	,	,	,	_	8	punct	_
6	Pfizer	pfizer	NNP	_	8	nsubjpass	13:A0=PAG;8:A2=GOL
7	was	be	VBD	_	8	auxpass	_
8	given	give	VBN	pb=give.01	0	root	_
9	until	until	IN	_	8	prep	8:AM-TMP
10	May	may	NNP	_	9	pobj	_
11	26	0	CD	_	10	num	_
12	to	to	TO	p2=IN	13	aux	_
13	decide	decide	VB	pb=decide.01	8	advcl	8:AM-PRP
14	whether	whether	IN	p2=CC	16	complm	_
15	to	to	TO	_	16	aux	_
16	make	make	VB	pb=make.05	13	ccomp	13:A1=PPT
17	a	a	DT	_	19	det	_
18	formal	formal	JJ	_	19	amod	_
19	offer	offer	NN	_	16	dobj	16:AM-PRR
20	or	or	CC	_	16	cc	_
21	walk	walk	VB	p2=VBP|pb=walk.01	16	conj	_
22	away	away	RB	_	21	advmod	21:AM-DIR
23	.	.	.	_	8	punct	_

1	A	a	DT	_	3	det	_
2	Pfizer	pfizer	NNP	_	3	nn	_
3	spokesman	spokesman	NN	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	Monday	monday	NNP	_	4	npadvmod	4:AM-TMP
6	that	that	IN	_	10	complm	_
7	the	the	DT	_	8	det	_
8	company	company	NN	_	10	nsubj	10:A0=PAG
9	was	be	VBD	_	10	aux	_
10	evaluating	evaluate	VBG	pb=evaluate.01	4	ccomp	4:A1=PPT
11	its	its	PRP$	_	12	poss	_
12	options	option	NNS	_	10	dobj	10:A1=PPT
13	after	after	IN	_	10	prep	10:AM-TMP
14	the	the	DT	_	16	det	_
15	latest	late	JJS	_	16	amod	_
16	rejection	rejection	NN	_	13	pobj	_
17	.	.	.	_	4	punct	_

1	Leif	leif	NNP	p2=IN	2	nn	_
2	Johansson	johansson	NNP	_	8	nsubj	8:A0
3	,	,	,	_	2	punct	_
4	the	the	DT	_	6	det	_
5	AstraZeneca	astrazeneca	NNP	_	6	nn	_
6	chairman	chairman	NN	_	2	appos	_
7	,	,	,	_	2	punct	_
8	said	say	VBD	pb=say.01	0	root	_
9	in	in	IN	_	8	prep	8:AM-LOC
10	a	a	DT	_	11	det	_
11	statement	statement	NN	_	9	pobj	_
12	that	that	IN	_	18	complm	_
13	Pfizer	pfizer	NNP	_	15	poss	_
14	's	's	POS	_	13	possessive	_
15	pursuit	pursuit	NN	_	18	nsubj	18:A1=PPT;23:A1=PPT
16	all	all	RB	p2=DT	17	advmod	_
17	along	along	RB	p2=IN	18	advmod	18:AM-ADV
18	appeared	appear	VBD	p2=VBN|pb=appear.02	8	ccomp	8:A1=PPT
19	to	to	TO	_	23	aux	_
20	have	have	VB	_	23	aux	_
21	been	be	VBN	_	23	auxpass	_
22	fundamentally	fundamentally	RB	_	23	advmod	23:AM-MNR
23	driven	drive	VBN	pb=drive.02	18	xcomp	18:C-A1
24	by	by	IN	_	23	agent	23:A0=PAG
25	the	the	DT	_	28	det	_
26	corporate	corporate	JJ	_	28	amod	_
27	financial	financial	JJ	_	28	amod	_
28	benefits	benefit	NNS	_	24	pobj	_
29	to	to	IN	_	28	prep	_
30	its	its	PRP$	_	31	poss	_
31	shareholders	shareholder	NNS	_	29	pobj	_
32	of	of	IN	_	31	prep	_
33	cost	cost	NN	p2=JJ	34	nn	_
34	savings	saving	NNS	_	32	pobj	_
35	and	and	CC	_	34	cc	_
36	tax	tax	NN	_	37	nn	_
37	minimization	minimization	NN	_	34	conj	_
38	.	.	.	_	8	punct	_

1	``	``	``	_	39	punct	_
2	From	from	IN	_	25	prep	25:AM-TMP
3	our	our	PRP$	_	5	poss	_
4	first	#ord#	JJ	_	5	amod	_
5	meeting	meeting	NN	_	2	pobj	_
6	in	in	IN	_	5	prep	_
7	January	january	NNP	_	6	pobj	_
8	to	to	IN	_	2	prep	_
9	our	our	PRP$	_	11	poss	_
10	latest	late	JJS	_	11	amod	_
11	discussion	discussion	NN	_	8	pobj	_
12	yesterday	yesterday	NN	_	2	npadvmod	_
13	,	,	,	_	2	punct	_
14	and	and	CC	_	2	cc	_
15	in	in	IN	_	25	prep	25:AM-LOC
16	the	the	DT	_	19	det	_
17	numerous	numerous	JJ	_	19	amod	_
18	phone	phone	NN	_	19	nn	_
19	calls	call	NNS	p2=VBZ	15	pobj	_
20	in	in	IN	p2=RP	19	prep	_
21	between	between	IN	p2=NN	19	prep	_
22	,	,	,	_	25	punct	_
23	Pfizer	pfizer	NNP	_	25	nsubj	27:A0=PAG;25:A1=PAG
24	has	have	VBZ	_	25	aux	_
25	failed	fail	VBN	pb=fail.01	39	ccomp	39:A1=PPT
26	to	to	TO	_	27	aux	_
27	make	make	VB	pb=make.02	25	xcomp	25:A2=PPT
28	a	a	DT	_	35	det	_
29	compelling	compelling	JJ	_	35	amod	_
30	strategic	strategic	JJ	_	35	amod	_
31	,	,	,	_	30	punct	_
32	business	business	NN	_	35	nn	_
33	or	or	CC	_	32	cc	_
34	value	value	NN	_	32	conj	_
35	case	case	NN	_	27	dobj	27:A1=PRD
36	,	,	,	_	39	punct	_
37	''	''	''	_	39	punct	_
38	Johansson	johansson	NNP	_	39	nsubj	39:A0
39	said	say	VBD	pb=say.01	0	root	_
40	.	.	.	_	39	punct	_

1	The	the	DT	_	2	det	_
2	board	board	NN	_	3	nsubj	3:A1=PPT
3	is	be	VBZ	pb=be.01	0	root	_
4	firm	firm	JJ	p2=NN	3	acomp	3:A2=PRD
5	in	in	IN	_	4	prep	_
6	its	its	PRP$	_	7	poss	_
7	conviction	conviction	NN	_	5	pobj	_
8	as	as	IN	p2=RB	7	prep	_
9	to	to	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	appropriate	appropriate	JJ	_	12	amod	_
12	terms	term	NNS	_	9	pobj	_
13	to	to	TO	_	14	aux	_
14	recommend	recommend	VB	pb=recommend.01	12	infmod	_
15	to	to	IN	_	14	prep	14:A2=GOL
16	shareholders	shareholder	NNS	_	15	pobj	_
17	.	.	.	_	3	punct	_

1	Sundays	sunday	NNS	p2=NNPS	2	nn	2:A0=PAG
2	offer	offer	VBP	p2=NN|pb=offer.01	0	root	_
3	represented	represented	VBN	p2=VBD	2	prep	2:AM-MNR
4	a	a	DT	_	8	det	_
5	45	0	CD	_	7	num	_
6	per	per	NN	_	7	nn	_
7	cent	cent	NN	_	8	nn	_
8	premium	premium	NN	_	3	dobj	_
9	over	over	IN	_	8	prep	_
10	AstraZenecas	astrazenecas	NNP	p2=JJ	12	nn	_
11	share	share	NN	p2=VBP	12	nn	_
12	price	price	NN	_	9	pobj	_
13	before	before	IN	_	19	mark	_
14	news	news	NN	_	19	nsubj	19:A1=PPT;24:A1=PPT
15	of	of	IN	_	14	prep	_
16	Pfizer	pfizer	NNP	_	18	poss	_
17	's	's	POS	_	16	possessive	_
18	interest	interest	NN	_	15	pobj	_
19	became	become	VBD	pb=become.01	3	advcl	_
20	public	public	JJ	p2=NN	19	acomp	19:A2=PRD
21	in	in	IN	_	19	prep	19:AM-TMP
22	April	april	NNP	_	21	pobj	_
23	and	and	CC	_	19	cc	_
24	came	come	VBD	pb=come.01	19	conj	_
25	after	after	IN	_	24	prep	24:AM-TMP
26	a	a	DT	_	28	det	_
27	previous	previous	JJ	_	28	amod	_
28	offer	offer	NN	_	25	pobj	_
29	by	by	IN	_	28	prep	_
30	Pfizer	pfizer	NNP	_	29	pobj	_
31	late	late	JJ	p2=RB	32	amod	_
32	Friday	friday	NNP	_	24	npadvmod	24:AM-TMP
33	.	.	.	_	2	punct	_

1	The	the	DT	_	3	det	_
2	latest	late	JJS	_	3	amod	_
3	proposal	proposal	NN	_	6	nsubj	6:A0=PAG
4	would	would	MD	_	6	aux	6:AM-MOD
5	have	have	VB	_	6	aux	_
6	given	give	VBN	pb=give.01	0	root	_
7	AstraZeneca	astrazeneca	NNP	_	8	nn	_
8	shareholders	shareholder	NNS	_	6	iobj	6:A2=GOL
9	1.747	0	CD	_	10	num	_
10	shares	share	NNS	_	6	dobj	6:A1=PPT
11	of	of	IN	_	10	prep	_
12	the	the	DT	_	14	det	_
13	combined	combine	VBN	p2=JJ|pb=combine.01	14	amod	_
14	company	company	NN	_	11	pobj	13:A1=PPT
15	,	,	,	_	6	punct	_
16	and	and	CC	_	6	cc	_
17	24.76	0	CD	_	18	num	_
18	pounds	pound	NNS	_	6	dobj	_
19	in	in	IN	_	18	prep	_
20	cash	cash	NN	_	19	pobj	_
21	for	for	IN	_	18	prep	_
22	each	each	DT	_	21	pobj	_
23	of	of	IN	_	22	prep	_
24	their	their	PRP$	_	25	poss	_
25	shares	share	NNS	_	23	pobj	_
26	.	.	.	_	6	punct	_

1	The	the	DT	_	2	det	_
2	offer	offer	NN	p2=VBP	3	nsubj	3:A0
3	valued	value	VBD	p2=VBN|pb=value.01	0	root	_
4	each	each	DT	_	5	det	_
5	share	share	NN	_	3	dobj	3:A1
6	of	of	IN	_	5	prep	_
7	AstraZeneca	astrazeneca	NNP	_	6	pobj	_
8	at	at	IN	_	3	prep	3:A2=PRD
9	about	about	RB	p2=IN	10	advmod	_
10	55	0	CD	_	11	num	_
11	pounds	pound	NNS	_	8	pobj	_
12	(	(	-LRB-	_	11	punct	_
13	$	$	$	_	14	nmod	_
14	92.50	0	CD	_	11	appos	_
15	)	)	-RRB-	_	11	punct	_
16	.	.	.	_	3	punct	_

1	AstraZeneca	astrazeneca	NNP	_	14	nsubj	4:A0=PAG;14:A0
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	4	nsubj	4:R-A0
4	has	have	VBZ	pb=have.03	1	rcmod	_
5	an	an	DT	_	7	det	_
6	attractive	attractive	JJ	_	7	amod	_
7	portfolio	portfolio	NN	_	4	dobj	4:A1=PPT
8	of	of	IN	_	7	prep	_
9	cancer	cancer	NN	_	10	nn	_
10	drugs	drug	NNS	_	8	pobj	_
11	,	,	,	_	14	punct	_
12	has	have	VBZ	_	14	aux	_
13	repeatedly	repeatedly	RB	_	14	advmod	14:AM-MNR
14	said	say	VBN	pb=say.01	0	root	_
15	that	that	IN	_	18	complm	_
16	it	it	PRP	_	18	nsubj	18:A0=PAG;20:A1=PPT
17	could	could	MD	_	18	aux	18:AM-MOD
18	continue	continue	VB	pb=continue.01	14	ccomp	14:A1=PPT
19	to	to	TO	_	20	aux	_
20	operate	operate	VB	pb=operate.01	18	xcomp	18:A1=PPT
21	as	as	IN	_	20	prep	20:A3=PRD
22	a	a	DT	_	26	det	_
23	stand	stand	VB	p2=NN	26	nn	_
24	-	-	HYPH	_	23	hyph	_
25	alone	alone	RB	p2=RP	23	advmod	_
26	company	company	NN	_	21	pobj	_
27	and	and	CC	_	18	cc	_
28	had	have	VBD	_	30	aux	_
29	recently	recently	RB	_	30	advmod	30:AM-TMP
30	talked	talk	VBN	pb=talk.01	18	conj	_
31	about	about	IN	_	30	prep	30:A1=PPT
32	the	the	DT	_	34	det	_
33	positive	positive	JJ	_	34	amod	_
34	results	result	NNS	_	31	pobj	_
35	of	of	IN	_	34	prep	_
36	several	several	JJ	_	38	amod	_
37	clinical	clinical	JJ	_	38	amod	_
38	trials	trial	NNS	_	35	pobj	_
39	in	in	IN	_	38	prep	_
40	an	an	DT	_	41	det	_
41	effort	effort	NN	_	39	pobj	_
42	to	to	TO	_	43	aux	_
43	highlight	highlight	VB	pb=highlight.01	41	infmod	_
44	its	its	PRP$	_	45	poss	_
45	prospects	prospect	NNS	_	43	dobj	43:A1=PPT
46	.	.	.	_	14	punct	_

